| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193642 | Annals of Allergy, Asthma & Immunology | 2006 | 4 Pages |
Abstract
Desensitization may permit the continued use of amprenavir in HIV-positive patients with a history of amprenavir-induced maculopapular eruptions who have limited alternate treatment options.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Anita MD, Phu PharmD, Francis MD,